Acadia Shareholder's Suit Ends In $15.75M Deal
An Acadia Pharmaceuticals Inc. shareholder has negotiated a $15.75 million settlement to resolve his New York federal court claims that RA Capital Management LLC colluded with two investors to score millions...To view the full article, register now.
Already a subscriber? Click here to view full article